Finance

Beta
Ask
Lists
4NH:FRA
Tchaikapharma High Quality Medicines AD
€8.70
-1.69%
(-0.15) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4NH...
Open
€8.70
High
€8.70
Low
€8.70
Mkt. cap
857.90M
Avg. vol.
0.00
Volume
0.00
P/E ratio
219.81
52-wk high
€9.15
52-wk low
€0.01
EPS
€0.04
No. of employees
214
Open
€8.70
High
€8.70
Low
€8.70
Mkt. cap
857.90M
Avg. vol.
0.00
Volume
0.00
P/E ratio
219.81
52-wk high
€9.15
52-wk low
€0.01
EPS
€0.04
No. of employees
214
News stories
From sources across the web
About Tchaikapharma High Quality Medicines AD
CEO-
Employees214
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitetchaikapharma.com
Previous reportsAll values in BGN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BGN
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
16.19M
15.87M
15.93M
16.01M
Cost of goods sold
5.43M
4.53M
4.72M
3.36M
Cost of revenue
5.43M
4.53M
4.72M
3.36M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.41M
7.62M
8.24M
12.61M
Operating expense
8.24M
8.52M
9.10M
13.54M
Total operating expenses
13.66M
13.05M
13.83M
16.89M
Operating income
2.53M
2.82M
2.10M
-883.00K
Other non operating income
-6.00K
-5.00K
-5.00K
-26.00K
EBT including unusual items
2.38M
2.73M
1.98M
-453.00K
EBT excluding unusual items
2.38M
2.73M
1.98M
-453.00K
Income tax expense
220.00K
110.00K
165.00K
132.00K
Effective tax rate
9.22%
4.03%
8.34%
-29.14%
Other operating expenses
122.00K
221.00K
125.00K
184.00K
Net income
2.16M
2.62M
1.81M
-585.00K
Net profit margin
13.37%
16.51%
11.38%
-3.65%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
583.00K
Interest expense
-123.00K
-110.00K
-108.00K
-122.00K
Net interest expenses
-123.00K
-110.00K
-108.00K
461.00K
Depreciation and amortization charges
707.00K
678.00K
744.00K
743.00K
EBITDA
3.23M
3.13M
3.61M
-140.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer